US 8202520
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
granted A61KA61K2039/6037A61K2039/6068
Quick answer
US patent 8202520 (Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/6037, A61K2039/6068, A61K2039/627, A61K39/0275